This is unpublished

Shaveta
Vinayak
M.D.
M.S.

she, her, hers
Physician & Research Faculty
Pinned
Academic
Assistant Professor, Division of Medical Oncology, University of Washington
Assistant Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Sites of Practice
Seattle Cancer Care Alliance

Photo: SCCA

Education, Training, Board Certifications 

  • M.D., Virginia Commonwealth University  
  • M.S. in Physiology and Biophysics, Georgetown University 
  • Residency, Albert Einstein College of Medicine 
  • Fellowship in Oncology, Stanford University 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise

  • Breast cancer

Affiliations  

Publications

Research and/or clinical interests  

Dr. Shaveta Vinayak a medical oncologist who specializes in the treatment of breast cancer. Her research is focused on an aggressive subtype known as triple-negative breast cancer, which tends to affect younger people and those with a BRCA1 gene mutation. She designs and leads clinical trials that explore targeted therapies like immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells, and PARP inhibitors, a type of drug that may prevent cancer cells from fixing the damage caused by chemotherapy. PARP inhibitors may hold particular promise for people with BRCA-related cancers. In addition to treating patients and conducting research, Dr. Vinayak also leads education seminars about triple-negative breast cancer for African American women, who are three times more likely to be diagnosed with this form of cancer than women of other ethnicities.